Phoenix Holdings Ltd. Sol Gel Technologies Ltd. Transaction History

Phoenix Holdings Ltd.

  • $6.92 Billion
  • Q1 2024

A detailed history of Phoenix Holdings Ltd. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 2,574,922 shares of SLGL stock, worth $2.21 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,574,922
Previous 2,574,922 -0.0%
Holding current value
$2.21 Million
Previous $2.83 Million 10.91%
% of portfolio
0.04%
Previous 0.05%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$6.57 - $9.78 $238,169 - $354,534
-36,251 Reduced 1.39%
2,574,922 $19.1 Million
Q3 2021

Oct 27, 2021
SELL
$8.85 - $12.5 $1,955 - $2,762
-221 Reduced 0.01%
2,611,173 $26.1 Million
Q2 2021

Aug 10, 2021
BUY
$9.53 - $14.7 $795,812 - $1.23 Million
83,506 Added 3.3%
2,611,394 $32.3 Million
Q1 2021

May 10, 2021
SELL
$8.75 - $15.49 $1.27 Million - $2.25 Million
-145,056 Reduced 5.43%
2,527,888 $31.3 Million
Q4 2020

Feb 11, 2021
SELL
$7.11 - $9.99 $197,985 - $278,181
-27,846 Reduced 1.03%
2,672,944 $26.1 Million
Q3 2020

Nov 10, 2020
SELL
$7.15 - $8.73 $7,557 - $9,227
-1,057 Reduced 0.04%
2,700,790 $18.4 Million
Q1 2020

May 20, 2020
BUY
$5.88 - $15.75 $3.48 Million - $9.33 Million
592,068 Added 28.06%
2,701,847 $18.6 Million
Q4 2019

Feb 18, 2020
BUY
$7.5 - $17.15 $545,115 - $1.25 Million
72,682 Added 3.57%
2,109,779 $35.9 Million
Q3 2019

Nov 18, 2019
BUY
$7.7 - $10.48 $15.7 Million - $21.3 Million
2,037,097 New
2,037,097 $17.5 Million

Others Institutions Holding SLGL

# of Institutions
23
Shares Held
7.7M
Call Options Held
200
Put Options Held
300
View Full List

About Sol-Gel Technologies Ltd.

SLGL Quotes by TradingView
  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $19.9M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email